Optimi Health Corp. Common Shares (OPTH)
OPTH trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.50
-3.58% on the day
Market cap
$20.0M
Nano cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | OPTH on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0002027329 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-08-27 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-07 |
Source: SEC EDGAR submissions feed, 45 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals Ltd. | $4.15 | -4.82% | $19.9M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| AYTU | Aytu BioPharma Inc. | $1.99 | +1.01% | $21.6M |
| NEUP | Neuphoria Therapeutics Inc. | $3.39 | +2.11% | $18.3M |
| AKTX | Akari Therapeutics plc ADS | $7.90 | -7.49% | $18.1M |
| TXMD | TherapeuticsMD Inc. | $1.96 | -2.97% | $22.7M |
| RADX | Radiopharm Theranostics Limited | $1.20 | +8.10% | $17.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier